Alembic Pharmaceuticals Ltd.

Financial

	Alembic Pharma	Jubilant Pharmova	Natco Pharma
Operational Metrics
Pharmaceutical Sector
US DMF Filings	140.0 .	98.0 .	58.0 .
Number of ANDA's Filed in USA	268.0 .	100.0 .	51.0 .
Number of ANDA's Approved By USFDA	223.0 .	62.0 .	41.0 .
Number of ANDA's Filed in Latam	14.0	n/a	n/a
Number of ANDA's Approved by Latam	4.0	n/a	n/a
Number of ANDA's Filed in South Africa	21.0	n/a	n/a
Number of ANDA's Approved by South Africa	7.0	n/a	n/a
Number of ANDA's Filed in Australia	17.0	n/a	n/a
Number of ANDA's Approved by Australia	14.0	n/a	n/a
Number of ANDA's Filed in Canada	21.0	24.0	n/a
Number of ANDA's Approved by Canada	20.0	24.0	n/a
Number of ANDA's Filed in Europe	21.0	38.0	n/a
Number of ANDA's Approved in Europe	19.0	37.0	n/a
R&D as a % of Total Sales	8.0 %	0.18 %	7.6 %
Financials
5 yr Average ROE	12.89 %	8.35 %	13.06 %
5yr average Equity Multiplier	1.39	2.0	1.18
5yr Average Asset Turnover Ratio	0.86	0.59	0.46
5yr Avg Net Profit Margin	11.15 %	7.13 %	23.09 %
Price to Book	3.59	2.81	2.16
P/E	30.86	38.22	8.72
5yr Avg Cash Conversion Cycle	9.46 Days	-19.21 Days	10.54 Days
Inventory Days	99.1 Days	74.06 Days	99.95 Days
Days Receivable	66.32 Days	45.59 Days	86.16 Days
Days Payable	164.9 Days	149.89 Days	154.15 Days
5yr Average Interest Coverage Ratio	30.59	3.78	46.61
5yr Avg ROCE	15.26 %	9.05 %	16.05 %
5yr Avg Operating Profit Margin	17.29 %	18.69 %	30.17 %
5 yr average Debt to Equity	0.14	0.64	0.06
5yr CAGR Net Profit	-12.64 %	0.08 %	24.68 %
5yr Average Return on Assets	9.32 %	4.23 %	11.07 %
Shareholdings
Promoter Holding	69.67 %	47.68 %	49.56 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.06 %	-3.0 %	0.76 %
Change in Mutual Fund Holding (3 Yrs)	4.04 %	5.97 %	-4.64 %

Business

	Alembic Pharma	Jubilant Pharmova	Natco Pharma
Product Wise Break-Up	Product Wise Break-Up Formulations 84.75 Active Pharmaceutical Ingredient (API) 15.25 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Crop Health 0 API(Domestic & Exports) 0 Formulation 0	Product Wise Break-Up Formulation 0 Formulations 0 Active Pharmaceutical Ingredient (API) 9.26 Nutritional products 0 Anti-allergic 10.21 Contract Manufacturing 16.81 Crop Health 0 Life science chemicals 0 Contract Research and Development Services 6.7 API(Domestic & Exports) 0 India branded pharmaceuticals 0.72 Radiopharmaceuticals 44.9 Solid dosage formulations 10.82 Specialty intermediates 0 Active Pharmaceutical Ingredient (API) 0 Others 0.58	Product Wise Break-Up Formulations 89.5 Formulations 0 Active pharmaceutical ingredients 0 Nutritional products 0 Allergy therapy products 0 0 Crop Protection 1.2 Life science chemicals 0 0 Active Pharmaceutical Ingredient (API) 3.6 India Branded pharmaceuticals 0 Radiopharmaceuticals 0 Solid dosage formulations 0 Specialty intermediates 0 Active Pharmaceutical Ingredient (API) 0 Others 5.7
Product Wise Break-Up	Product Wise Break-Up Formulations 84.75 Active Pharmaceutical Ingredient (API) 15.25 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Crop Health 0 API(Domestic & Exports) 0 Formulation 0	Product Wise Break-Up Formulation 0 Formulations 0 Active Pharmaceutical Ingredient (API) 9.26 Nutritional products 0 Anti-allergic 10.21 Contract Manufacturing 16.81 Crop Health 0 Life science chemicals 0 Contract Research and Development Services 6.7 API(Domestic & Exports) 0 India branded pharmaceuticals 0.72 Radiopharmaceuticals 44.9 Solid dosage formulations 10.82 Specialty intermediates 0 Active Pharmaceutical Ingredient (API) 0 Others 0.58	Product Wise Break-Up Formulations 89.5 Formulations 0 Active pharmaceutical ingredients 0 Nutritional products 0 Allergy therapy products 0 0 Crop Protection 1.2 Life science chemicals 0 0 Active Pharmaceutical Ingredient (API) 3.6 India Branded pharmaceuticals 0 Radiopharmaceuticals 0 Solid dosage formulations 0 Specialty intermediates 0 Active Pharmaceutical Ingredient (API) 0 Others 5.7
Location Wise Break-Up	Location Wise Break-Up Rest of the World 60.76 India 39.24 China 0 Americas and Europe 0 USA 0	Location Wise Break-Up India 2.33 USA 0 China 0 Rest of the World 7.5 Americas and Europe 90.17	Location Wise Break-Up India 14.27 USA 70.49 China 0 Rest of the World 15.24 Americas and Europe 0
Therapeutic Area Break-Up	Therapeutic Area Break-Up Others 100	-	-

Alembic Pharmaceuticals Ltd.

Alembic Pharmaceuticals Ltd.

SIGN UP FOR FREE